» Articles » PMID: 37515299

Fatty Acids Composition and HIV Infection: Altered Levels of N-6 Polyunsaturated Fatty Acids Are Associated with Disease Progression

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Jul 29
PMID 37515299
Authors
Affiliations
Soon will be listed here.
Abstract

Fatty acids (FAs) are important regulators of immune responses and innate defense mechanisms. We hypothesized that disturbed FA metabolism could contribute to the progression of HIV infection. Plasma levels of 45 FAs were analyzed with gas chromatography in healthy controls and HIV-infected patients with regard to Mycobacterium avium complex (MAC) infection. In vitro, we assessed MAC-PPD-induced release of inflammatory cytokines in peripheral and bone marrow mononuclear cells (PBMC and BMMC) according to levels of n-6 polyunsaturated fatty acids (PUFAs). While plasma saturated FAs were higher in HIV infection, PUFAs, and in particular the n-6 PUFA arachidonic acid (AA), were lower in patients with advanced disease. The ratio between AA and precursor dihomo-γ-linolenic acid, reflecting Δ5-desaturase activity, was markedly lower and inversely correlated with plasma HIV RNA levels in these patients. Depletion of AA was observed prior to MAC infection, and MAC-PPD-induced release of TNF and IL-6 in PBMC and BMMC was lower in patients with low plasma AA. Our findings suggest that dysregulated metabolism of n-6 PUFAs may play a role in the progression of HIV infection. While high AA may contribute to chronic inflammation in asymptomatic HIV-infected patients, low AA seems to increase the susceptibility to MAC infection in patients with advanced disease.

Citing Articles

Distinct metabolic perturbations link liver steatosis and incident CVD in lean but not obese PWH.

van Eekeren L, Vadaq N, Blaauw M, Groenendijk A, Vos W, Nelwan E BMC Med. 2025; 23(1):78.

PMID: 39934780 PMC: 11817758. DOI: 10.1186/s12916-025-03914-5.


Mechanisms of HIV-immunologic non-responses and research trends based on gut microbiota.

Sun X, Xie Z, Wu Z, Song M, Zhang Y, Zhang Z Front Immunol. 2025; 15():1378431.

PMID: 39802299 PMC: 11718445. DOI: 10.3389/fimmu.2024.1378431.


Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimod.

Abdel-Mohsen M, Deeks S, Giron L, Hong K, Goldman A, Zhang L Front Immunol. 2024; 15:1405348.

PMID: 38979421 PMC: 11229794. DOI: 10.3389/fimmu.2024.1405348.


Contributing to the management of viral infections through simple immunosensing of the arachidonic acid serum level.

Torrente-Rodriguez R, Ruiz-Valdepenas Montiel V, Iftimie S, Montero-Calle A, Pingarron J, Castro A Mikrochim Acta. 2024; 191(7):369.

PMID: 38834823 PMC: 11150294. DOI: 10.1007/s00604-024-06440-y.

References
1.
Kidani Y, Bensinger S . Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Immunol Rev. 2012; 249(1):72-83. PMC: 4007066. DOI: 10.1111/j.1600-065X.2012.01153.x. View

2.
Snodgrass R, Huang S, Choi I, Rutledge J, Hwang D . Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids. J Immunol. 2013; 191(8):4337-47. PMC: 3825708. DOI: 10.4049/jimmunol.1300298. View

3.
Klatt N, Funderburg N, Brenchley J . Microbial translocation, immune activation, and HIV disease. Trends Microbiol. 2012; 21(1):6-13. PMC: 3534808. DOI: 10.1016/j.tim.2012.09.001. View

4.
Troseid M, Nowak P, Nystrom J, Lindkvist A, Abdurahman S, Sonnerborg A . Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy. AIDS. 2010; 24(11):1733-7. DOI: 10.1097/QAD.0b013e32833b254d. View

5.
Pearce E, Walsh M, Cejas P, Harms G, Shen H, Wang L . Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009; 460(7251):103-7. PMC: 2803086. DOI: 10.1038/nature08097. View